Falls Church, VANCT04419480Now EnrollingIRB Ready

Cardiogenic Shock Clinical Trial in Falls Church, VA

Access cutting-edge cardiogenic shock treatment through this clinical trial at a research site in Falls Church. Study-provided care at no cost to qualified participants.

Sponsored by Inova Health Care Services

Quick Self-Assessment

See if you qualify for this Falls Church location

Preparing your pre-screening questions…

Expert Care in Falls Church

Access cardiogenic shock specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cardiogenic shock treatment provided free

Apply for This Falls Church Location

Check if you qualify for this cardiogenic shock clinical trial in Falls Church, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Falls Church

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Falls Church site if eligible
  4. 4Begin participation

About This Cardiogenic Shock Study in Falls Church

Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock

Sponsor: Inova Health Care Services

Who Can Participate

Inclusion Criteria

Subject or legal representative has signed Informed Consent Form (ICF) and the patient has the capacity to participate in the study and complete the study questionnaires, in the estimation of the study investigator.
Age ≥ 18 years
NYHA Class III with dyspnea upon mild physical activity, regardless of left ventricular ejection fraction (LVEF).
Survive to discharge during a current hospital admission with cardiogenic shock (CS) as defined by clinical criteria previously used in cardiogenic shock trials: systolic blood pressure \< 90 mmHg for \> 30 minutes or requiring infusion of catecholamines to maintain the systolic blood pressure above 90 mmHg, with evidence of end-organ dysfunction such as pulmonary edema or impaired end-organ perfusion including altered mentation, oliguria with urine output \< 30 mL/h, or serum lactate \> 2 mmol/L (5). Hemodynamic criteria include cardiac index ≤ 1.8 L/min/m2 without vasoactive pharmacologic agents, or cardiac index ≤ 2.2 L/min/m2 and pulmonary artery occlusion pressure ≥ 15 mmHg with vasoactive agents.
Patients must have internet and phone access (to allow communication of the implanted device with the researchers).

Exclusion Criteria

Technical obstacles which pose an inordinately high procedural risk, in the judgment of the investigator.
Treatment with ongoing mechanical circulatory support (MCS) such as a durable left ventricular assist device (LVAD) or recipient of a heart transplantation for the treatment of cardiogenic shock during the index hospitalization for CS.
If of childbearing potential with a positive pregnancy test.
Transition to hospice care.
Intolerance to or inability to adhere to antiplatelet therapy for 1 year after device implantation.
Presence of an active, uncontrolled infection.
Any condition other than heart failure that could limit survival to less than 6 months
Discharge to facility other than acute rehabilitation or to the ambulatory setting.
No access to internet or phone.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Falls Church?

Yes, this clinical trial (NCT04419480) has an active research site in Falls Church, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cardiogenic Shock Treatment Options in Falls Church, VA

If you're searching for cardiogenic shock treatment options in Falls Church, VA, this clinical trial (NCT04419480) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Falls Church research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiogenic shock specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cardiogenic shock clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in Falls Church, VA

See all interstitial cystitis clinical trials recruiting in Falls Church — not just this study.

Browse Interstitial Cystitis Trials in Falls Church →

Browse More Trials by Condition

Interstitial Cystitis TrialsAll Conditions →

Ready to Join in Falls Church?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Falls Church, VA